Results 171 to 180 of about 3,222 (233)

Metabolism of a New Antiaggregant, Indolinone Derivative

Bulletin of Experimental Biology and Medicine, 2020
Cytochrome p450-mediated metabolism of GRS (indolinone antiaggregant) and its effects on activities of cytochrome p450 isoenzymes were studied. Inhibition of 6 isomers of cytochrome p450 in human liver microsomes was studied with the use of specific substrates.
Galina A Chernysheva   +2 more
exaly   +3 more sources

Antiaggregant Activity of a New Benzimidazole Derivative

Bulletin of Experimental Biology and Medicine, 2014
Antiaggregant activity of a new tricyclic benzimidazole derivative, RU-891 compound, was studied on the model of ADP-induced platelet aggregation in vitro and intravascular platelet aggregation in vivo. We evaluated the effect of this substance on blood coagulation potential. Antiaggregant agent acetylsalicylic acid was used as the reference drug.
Alexander A Spasov   +2 more
exaly   +3 more sources

Xenon Antiaggregant Effects

Bulletin of Experimental Biology and Medicine, 2023
In in vitro model of short-term therapeutic inhalation of Xe/O2 mixture, xenon in millimolar concentrations led to a pronounced decrease in induced platelet aggregation in the platelet-enriched blood plasma. The maximum and statistically significant decrease occurred in response to induction by collagen (by ≈30%, p≤0.01) and ADP (by ≈25%, p≤0.01).
V V, Udut   +8 more
openaire   +2 more sources

Antiaggregant effects of biogenic chloramines

Bulletin of Experimental Biology and Medicine, 2007
Alanine and taurine sharply potentiate antiaggregant effects of hypochlorite on platelets in platelet-rich plasma. This effect is determined by more pronounced action of chloramine derivatives, products of interaction of added amino acids with hypochlorite.
M A, Murina   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy